Contents

Recent Patents on Cardiovascular Drug Discovery (Discontinued), Volume 1 - Number 2

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase

, 1(2): 129 - 139

Nangaku Nangaku, Ichiro Kojima, Tetsuhiro Tanaka, Takamoto Ohse, Hideki Kato and Fujita Fujita


DOI: 10.2174/157489006777442522




Potential Applications of RNA Interference-Based Therapeutics in the Treatment of Cardiovascular Disease

, 1(2): 141 - 149

Ali Hassan


DOI: 10.2174/157489006777442540




Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches

, 1(2): 151 - 159

Reiko Inagi


DOI: 10.2174/157489006777442450




99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review

, 1(2): 161 - 166

Tohoru Takeda, Jin Wu and Thet-Thet-Lwin


DOI: 10.2174/157489006777442496




Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications

, 1(2): 167 - 175

Zia A. Khan and Subrata Chakrabarti


DOI: 10.2174/157489006777442531




Vasopressin Receptor Antagonists in Heart Failure

, 1(2): 177 - 184

Robert E. Hobbs and W. H. Wilson Tang


DOI: 10.2174/157489006777442513




Levosimendan: A Novel Agent in Heart Failure

, 1(2): 185 - 191

Nikolas Koumallos, Charalambos Antoniades, Dimitris Tousoulis, Cheerag Shirodaria and Christodoulos Stefanadis


DOI: 10.2174/157489006777442487




Role of PPAR in Cardiovascular Diseases

, 1(2): 193 - 209

Saibal K. Das and Ranjan Chakrabarti


DOI: 10.2174/157489006777442441




Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs

, 1(2): 211 - 224

Gregory J. Chen and Reza Forough


DOI: 10.2174/157489006777442478




Patent Annotations

, 1(2): 225 - 227


DOI: 10.2174/157489006777442504




Patent Selections

, 1(2): 229 - 231


DOI: 10.2174/157489006777442469




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science